scholarly journals Determination of Antibody Titer to Bartonella henselae by Indirect Fluorescence Antibody Assay using B. henselae from Domestic Cats as Antigen

2005 ◽  
Vol 79 (10) ◽  
pp. 826-828 ◽  
Author(s):  
Hidehiro TSUNEOKA ◽  
Chizuru ISHIDA ◽  
Masato TSUKAHARA
Keyword(s):  
Antibody Titer ◽  
Bartonella Henselae ◽  
Domestic Cats ◽  
Antibody Assay ◽  
Fluorescence Antibody ◽  
Indirect Fluorescence Antibody

scholarly journals Determination of Anti-Bartonella henselae Antibody by Indirect Fluorescence Antibody Test

1998 ◽  
Vol 72 (8) ◽  
pp. 801-807 ◽  
Author(s):  
Hidehiro TSUNEOKA ◽  
Reiko FUJII ◽  
Kiyomi YAMAMOTO ◽  
Keiko FUJISAWA ◽  
Hidechika IINO ◽  
...  
Keyword(s):  
Bartonella Henselae ◽  
Antibody Test ◽  
Indirect Fluorescence Antibody Test ◽  
Fluorescence Antibody ◽  
Indirect Fluorescence Antibody

scholarly journals Exposure of Domestic Cats to Distinct Ehrlichia canis TRP Genotypes

2021 ◽  
Vol 8 (12) ◽  
pp. 310
Author(s):  
Ísis Assis Braga ◽  
Isis Indaiara Gonçalves Granjeiro Taques ◽  
Estefânia Crivelatti Grontoski ◽  
Ingrid Savino de Oliveira Dias ◽  
Nathalia Assis Pereira ◽  
...  
Keyword(s):  
Antibody Test ◽  
Ehrlichia Canis ◽  
Indirect Fluorescence Antibody Test ◽  
Domestic Cats ◽  
Serum Samples ◽  
Specific Antibodies ◽  
First Report ◽  
The World ◽  
Fluorescence Antibody ◽  
Indirect Fluorescence Antibody

Cats naturally exposed to Ehrlichia canis have been described in different regions of the world, but little is known about the genotypes associated with infection in these animals. To detect E. canis-specific antibodies and investigate the E. canis TRP genotypes in cats, serum samples from 76 domestic cats reactive to crude E. canis antigens by the indirect fluorescence antibody test (IFAT) were analyzed by ELISA, using E. canis-specific peptides (i.e., TRP19 and TRP36 /BR/US/CR). Of these, 25 (32.9%) cats reacted to at least one TRP peptide, confirming their specific exposure to E. canis. Eighteen (23.7%) cats reacted to TRP19, 15 (19.8%) to BRTRP36, and 11 (14.5%) to USTRP36, but none of them reacted to CRTRP36. Eight (10.5%) cats reacted to TRP19 but not to any TRP36 genotype, demonstrating the possible existence of a new E. canis genotype infecting felines. Nevertheless, this study provides the first report of anti-E. canis-specific antibodies in domestic cats.

scholarly journals Serodiagnosis of Bartonella bacilliformis Infection by Indirect Fluorescence Antibody Assay: Test Development and Application to a Population in an Area of Bartonellosis Endemicity

2000 ◽  
Vol 38 (11) ◽  
pp. 4269-4271 ◽  
Author(s):  
Judith Chamberlin ◽  
Larry Laughlin ◽  
Scott Gordon ◽  
Sofia Romero ◽  
Nelson Solórzano ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Positive Predictive Value ◽  
Andes Mountains ◽  
Antibody Assay ◽  
Bartonella Bacilliformis ◽  
Blood Samples ◽  
The Andes ◽  
Life Threatening ◽  
Fluorescence Antibody ◽  
Indirect Fluorescence Antibody

Bartonella bacilliformis causes bartonellosis, a potentially life-threatening emerging infectious disease seen in the Andes Mountains of South America. There are no generally accepted serologic tests to confirm the disease. We developed an indirect fluorescence antibody (IFA) test for the detection of antibodies toB. bacilliformis and then tested its performance as an aid in the diagnosis of acute bartonellosis. The IFA is 82% sensitive in detecting B. bacilliformis antibodies in acute-phase blood samples of laboratory-confirmed bartonellosis patients. When used to examine convalescent-phase sera, the IFA is positive in 93% of bartonellosis cases. The positive predictive value of the test is 89% in an area of Peru where B. bacilliformis is endemic and where the point prevalence of infection is 45%.

scholarly journals Cervical Cat Scratch Disease Lymphadenitis in a Patient with Immunoglobulin M Antibodies to Toxoplasma gondii

2002 ◽  
Vol 9 (2) ◽  
pp. 496-498
Author(s):  
Mardjan Arvand ◽  
Ilkay Kazak ◽  
Sergije Jovanovic ◽  
Hans-Dieter Foss ◽  
Oliver Liesenfeld
Keyword(s):  
Toxoplasma Gondii ◽  
Clinical Symptoms ◽  
Bartonella Henselae ◽  
Cervical Lymphadenopathy ◽  
Immunoglobulin M ◽  
Cat Scratch Disease ◽  
Specific Immunoglobulin ◽  
Acute Toxoplasmosis

ABSTRACT We report on a young patient with chronic cervical lymphadenopathy and serological and histological evidence for infection with Bartonella henselae and Toxoplasma gondii. Serological follow-up studies, including testing for avidity of Toxoplasma-specific immunoglobulin G antibodies, assisted in the determination of the cause of the acute lymphadenitis. Our results suggest that the clinical symptoms were most likely due to cat scratch disease rather than to acute toxoplasmosis.

Malondialdehyde Assay in the Evaluation of Aspirin Antiplatelet Effects

Pharmacology ◽  
2018 ◽  
Vol 103 (1-2) ◽  
pp. 23-29 ◽  
Author(s):  
Amin Polzin ◽  
Lisa Dannenberg ◽  
Theresa Schneider ◽  
Betül Knoop ◽  
David Naguib ◽  
...  
Keyword(s):  
Cardiovascular Events ◽  
Operating Characteristic ◽  
Light Transmission ◽  
Platelet Reactivity ◽  
Area Under The Curve ◽  
Healthy Individuals ◽  
Antibody Assay ◽  
Light Transmission Aggregometry ◽  
Artery Disease

Aspirin is essential in secondary prevention of patients after myocardial infarction and with coronary artery disease. However, impaired pharmacodynamic response to aspirin is frequent (high on-treatment platelet reactivity [HTPR]). This leads to an enhanced prevalence of cardiovascular events and to an impaired clinical outcome. The current specific assays to evaluate aspirin antiplatelet effects are complex, time-consuming and demand for a high laboratory expertise. Therefore, we developed a potentially bedside assay based on the determination of malondialdehyde (MDA). MDA is a by-product of the thromboxane (TX) formation, which is synthesized in equimolar concentrations. In this study, we compared this MDA assay to the conventional assays in determination of pharmacodynamic aspirin response. For this, aspirin antiplatelet effects were measured in 22 healthy individuals and 63 aspirin treated patients using TX B2 formation enzyme-linked antibody assay, arachidonic acid induced light transmission aggregometry (LTA) and the new fluorometric MDA assay. In patients, MDA levels correlated well with TX formation (R = 0.81; 95% CI 0.69–0.88; p < 0.001) and LTA (R = 0.84; CI 0.74–0.91; p < 0.001). Receiver operating characteristic analyses revealed that the MDA assay does detect HTPR to aspirin sufficiently (area under the curve: 0.965; p < 0.001). The optimal cut-off was > 128 nmol/L (sensitivity of 100%, specificity of 91%). The new MDA assay is reliable in detecting HTPR. It is highly specific in the evaluation of antiplatelet effects by aspirin. This promising and potential bedside assay needs to be evaluated in clinical practice.

Sign in / Sign up

Export Citation Format

Share Document